Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy.

Stephenson AJ, Smith A, Kattan MW, Satagopan J, Reuter VE, Scardino PT, Gerald WL.

Cancer. 2005 Jul 15;104(2):290-8.

2.

External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.

Shariat SF, Walz J, Roehrborn CG, Zlotta AR, Perrotte P, Suardi N, Saad F, Karakiewicz PI.

J Clin Oncol. 2008 Mar 20;26(9):1526-31. doi: 10.1200/JCO.2007.12.4669.

PMID:
18349404
3.

A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.

Graefen M, Karakiewicz PI, Cagiannos I, Hammerer PG, Haese A, Palisaar J, Fernandez S, Noldus J, Erbersdobler A, Huland H, Scardino PT, Kattan MW.

Urol Oncol. 2002 Jul-Aug;7(4):141-6.

PMID:
12474529
4.

Gene based prediction of clinically localized prostate cancer progression after radical prostatectomy.

Talantov D, Jatkoe TA, Böhm M, Zhang Y, Ferguson AM, Stricker PD, Kattan MW, Sutherland RL, Kench JG, Wang Y, Henshall SM.

J Urol. 2010 Oct;184(4):1521-8. doi: 10.1016/j.juro.2010.05.084. Epub 2010 Aug 17.

PMID:
20723930
5.

Prediction of non-biochemical recurrence rate after radical prostatectomy in a Japanese cohort: development of a postoperative nomogram.

Okubo H, Ohori M, Ohno Y, Nakashima J, Inoue R, Nagao T, Tachibana M.

Int J Urol. 2014 May;21(5):479-83.

PMID:
24877254
6.

Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms.

Morote J, Del Amo J, Borque A, Ars E, Hernández C, Herranz F, Arruza A, Llarena R, Planas J, Viso MJ, Palou J, Raventós CX, Tejedor D, Artieda M, Simón L, Martínez A, Rioja LA.

J Urol. 2010 Aug;184(2):506-11. doi: 10.1016/j.juro.2010.03.144. Epub 2010 Jun 17.

PMID:
20620409
7.

Genetic predisposition to early recurrence in clinically localized prostate cancer.

Borque Á, del Amo J, Esteban LM, Ars E, Hernández C, Planas J, Arruza A, Llarena R, Palou J, Herranz F, Raventós CX, Tejedor D, Artieda M, Simon L, Martínez A, Carceller E, Suárez M, Allué M, Sanz G, Morote J.

BJU Int. 2013 Apr;111(4):549-58. doi: 10.1111/j.1464-410X.2012.11333.x. Epub 2012 Jul 3.

8.

Quantitative RT-PCR analysis of PSA and prostate-specific membrane antigen mRNA to detect circulating tumor cells improves recurrence-free survival nomogram prediction after radical prostatectomy.

Yates DR, Rouprêt M, Drouin SJ, Comperat E, Ricci S, Lacave R, Sèbe P, Cancel-Tassin G, Bitker MO, Cussenot O.

Prostate. 2012 Sep 1;72(12):1382-8. doi: 10.1002/pros.22488. Epub 2012 Jan 6.

PMID:
22228175
9.

Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy.

Rouprêt M, Hupertan V, Comperat E, Drouin SJ, Phé V, Xylinas E, Demanse D, Sibony M, Richard F, Cussenot O.

BJU Int. 2009 Sep;104(6):813-7; discussion 817-8. doi: 10.1111/j.1464-410X.2009.08473.x. Epub 2009 Feb 27.

10.

Novel Gene Expression Signature Predictive of Clinical Recurrence After Radical Prostatectomy in Early Stage Prostate Cancer Patients.

Shahabi A, Lewinger JP, Ren J, April C, Sherrod AE, Hacia JG, Daneshmand S, Gill I, Pinski JK, Fan JB, Stern MC.

Prostate. 2016 Oct;76(14):1239-56. doi: 10.1002/pros.23211. Epub 2016 Jun 8.

PMID:
27272349
11.

Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database.

Moreira DM, Jayachandran J, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, Amling CL, Stephenson AJ, Freedland SJ.

BJU Int. 2009 Nov;104(10):1452-6. doi: 10.1111/j.1464-410X.2009.08623.x. Epub 2009 May 18.

12.

Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence.

Lee BH, Kibel AS, Ciezki JP, Klein EA, Reddy CA, Yu C, Kattan MW, Stephenson AJ.

Eur Urol. 2015 Feb;67(2):204-9. doi: 10.1016/j.eururo.2014.09.017. Epub 2014 Oct 5.

PMID:
25294696
13.

Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.

Walz J, Chun FK, Klein EA, Reuther A, Saad F, Graefen M, Huland H, Karakiewicz PI.

J Urol. 2009 Feb;181(2):601-7; discussion 607-8. doi: 10.1016/j.juro.2008.10.033. Epub 2008 Dec 13.

PMID:
19084864
14.

Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer.

Graefen M, Karakiewicz PI, Cagiannos I, Klein E, Kupelian PA, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, de Kernion J, Cangiano T, Schröder FH, Wildhagen MF, Scardino PT, Kattan MW.

J Clin Oncol. 2002 Feb 15;20(4):951-6.

PMID:
11844816
15.

Use of expression analysis to predict outcome after radical prostatectomy.

Febbo PG, Sellers WR.

J Urol. 2003 Dec;170(6 Pt 2):S11-9; discussion S19-20.

PMID:
14610405
16.

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT.

J Natl Cancer Inst. 1998 May 20;90(10):766-71.

PMID:
9605647
17.
18.

A four gene signature predictive of recurrent prostate cancer.

Komisarof J, McCall M, Newman L, Bshara W, Mohler JL, Morrison C, Land H.

Oncotarget. 2017 Jan 10;8(2):3430-3440. doi: 10.18632/oncotarget.13837.

20.

International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.

Graefen M, Karakiewicz PI, Cagiannos I, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, Klein E, Kupelian P, Skinner DG, Lieskovsky G, Bochner B, Huland H, Hammerer PG, Haese A, Erbersdobler A, Eastham JA, de Kernion J, Cangiano T, Schröder FH, Wildhagen MF, van der Kwast TH, Scardino PT, Kattan MW.

J Clin Oncol. 2002 Aug 1;20(15):3206-12.

PMID:
12149292

Supplemental Content

Support Center